tiprankstipranks
Viatris Reports Strong 2024 Financial Results
PremiumCompany AnnouncementsViatris Reports Strong 2024 Financial Results
29d ago
Viatris, Inc. Earnings Call: Balancing Growth and Challenges
Premium
Company Announcements
Viatris, Inc. Earnings Call: Balancing Growth and Challenges
29d ago
Viatris sees FY25 adjusted EPS $2.12-$2.26, consensus $2.59
Premium
The Fly
Viatris sees FY25 adjusted EPS $2.12-$2.26, consensus $2.59
29d ago
Viatris announces publication of CARE study results
PremiumThe FlyViatris announces publication of CARE study results
3M ago
Viatris Elects Directors and Amends Stock Plan at Meeting
Premium
Company Announcements
Viatris Elects Directors and Amends Stock Plan at Meeting
4M ago
Viatris price target raised to $14 from $13 at Piper Sandler
Premium
The Fly
Viatris price target raised to $14 from $13 at Piper Sandler
4M ago
Lexicon signs licensing agreement with Viatris for sotagliflozin
PremiumThe FlyLexicon signs licensing agreement with Viatris for sotagliflozin
5M ago
Lexicon receives $25M upfront from Viatris for exclusive sotagliflozin license
Premium
The Fly
Lexicon receives $25M upfront from Viatris for exclusive sotagliflozin license
5M ago
Early notable gainers among liquid option names on October 15th
Premium
The Fly
Early notable gainers among liquid option names on October 15th
5M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100